This gender discrepancy of COVID-19–related morbidity and mortality can be attributed to a combination of biological sex differences, including differences in sex hormones involved in inflammatory processes and in expression levels of ACE2 and TMPRSS2, but literature data are not yet coherent (Gebhard et al., 2020; Haitao et al., 2020). Here, ACE2 is linked to COVID-19.